Skip to content

Study · Not a test of the peptide alone · 1992

1 result

Conformationally biased analogs of oxytocin.

Lebl M, Toth G, Slaninová J, Hruby VJ

International journal of peptide and protein research1 Aug 1992Cited by 11 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01LabNot a test of Oxytocin aloneOther designActivity measurement

    Four synthetic oxytocin analogs with substituted phenylalanine at position 2 inhibited the uterotonic activity of oxytocin, with pA2 values from 6.0 to 8.3.

    In plain wordsIn lab tests, four modified oxytocin-like molecules blocked the uterus-contracting action of oxytocin, with different strengths.

    Peptide
    Oxytocin
    Outcome
    Not applicableInhibition of oxytocin uterotonic activity by analogs
    Study

    n: not reported in source

    Outcome group
    Receptor activity and mechanism · Reproductive and sexual health

    Measurements

    pA2
    6 to 8.3 NA
    oxytocin analogs
    pA2
    8.3 NA
    dimethylphenylalanine D-erythro analog

    Source sentences

    Summary
    All analogs were found to be inhibitors of uterotonic activity of oxytocin with pA2 values ranging from 6.0 to 8.3; the most potent one (pA2 = 8.3) contained dimethylphenylalanine of the D-erythro configuration.
    1 context sentence
    Summary · context
    Four diastereomeric analogs of oxytocin containing substituted phenylalanine in position 2 were synthesized.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:52 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.